InflaRx N.V. announced that Jens Holstein has been appointed as a new board member of InflaRx, serving as Non-Executive Director. The appointment was approved by the Extraordinary General Meeting of shareholders held on September 21, 2018 in Amsterdam, the Netherlands. Mr. Holstein has extensive management experience in the biotechnology and healthcare industry and currently serves as CFO of Morphosys AG. Mr. Holstein currently serves as Chief Financial Officer of MorphoSys AG.